Digestive Health Panel

The Digestive Health Panel is a combined laboratory assessment that examines selected markers related to the intestines and stomach. It includes fecal calprotectin, testing for occult blood in stool, Helicobacter pylori typing, and a Gastro Panel measuring gastrin-17 and pepsinogen markers.

The panel may be considered when digestive symptoms persist, repeatedly return, or need a more structured initial laboratory assessment. Relevant concerns may include bloating after meals, abdominal pain and cramps after eating, diarrhea, constipation, or heartburn and upper abdominal discomfort.

The panel does not identify every possible cause of digestive symptoms and does not replace a medical examination. Its purpose is to provide several complementary laboratory findings that can help determine whether gastroenterology assessment, additional stool testing, abdominal ultrasound, gastroscopy, colonoscopy, or another diagnostic pathway should be considered.

Tests included in the Digestive Health Panel

Fecal calprotectin

Fecal calprotectin is a marker associated with inflammation in the intestinal tract. It is measured in stool and can help distinguish a pattern that may require investigation for intestinal inflammation from symptoms that are less likely to involve an active inflammatory process.

An elevated value does not establish a diagnosis by itself. Calprotectin can rise with inflammatory bowel disease, intestinal infection, certain medication effects, and other gastrointestinal conditions. A clearly abnormal result may lead to a gastroenterology examination, repeat calprotectin testing, microbiological or other targeted stool tests, and sometimes colonoscopy or imaging, depending on symptoms and medical history.

Occult blood in stool

The occult blood test looks for small amounts of gastrointestinal bleeding that may not be visible when looking at the stool. A positive result indicates that blood has been detected, but it does not show where the bleeding originates or what caused it.

Possible causes range from benign anorectal conditions to inflammation, polyps, ulcers, or changes elsewhere in the digestive tract. A positive result generally requires clinical interpretation. Depending on age, symptoms, anemia, family history, and previous findings, further evaluation may include a gastroenterology consultation, repeat testing, colonoscopy, gastroscopy, or other targeted assessment.

Helicobacter pylori typing

The H. pylori typing component assesses markers associated with Helicobacter pylori and helps characterize the detected infection pattern. The test evaluates urease together with the CagA and VacA virulence markers. These findings can provide additional information about whether H. pylori markers are present and about the characteristics of the detected pattern.

A positive result does not independently determine treatment. It should be reviewed together with symptoms, previous H. pylori treatment, medication use, and other findings. Persistent upper abdominal pain, recurrent heartburn, unexplained anemia, vomiting, swallowing problems, weight loss, or signs of bleeding may lead to gastroenterology assessment and gastroscopy even when laboratory testing has already been performed.

Gastro Panel: gastrin-17 and pepsinogens

The Gastro Panel is performed from a blood sample and includes gastrin-17, pepsinogen I, and pepsinogen II. The relationship between these markers provides information relevant to gastric acid secretion and the functional condition of the stomach lining.

Abnormal gastrin or pepsinogen findings may indicate that the stomach requires further evaluation, but they do not directly diagnose gastritis, an ulcer, precancerous change, or stomach cancer. Depending on the pattern and the patient’s symptoms, the next step may include a gastroenterology examination, additional blood testing, H. pylori evaluation, or gastroscopy with possible biopsy.

How testing is performed

Step 1: Review the collection instructions

The panel combines several tests that use different laboratory specimens. Current instructions should therefore be reviewed before sample collection. They specify which containers are required and how each sample should be labeled, stored, and delivered.

Step 2: Collect the required stool sample

Stool is required for the fecal components of the panel. The sample is collected in an approved container and submitted according to the supplied instructions. Correct collection helps reduce the risk of an unusable or difficult-to-interpret result.

Step 3: Venous blood sampling

A venous blood sample is taken for the Gastro Panel. Blood collection is brief and is usually completed as an outpatient laboratory procedure.

Step 4: Laboratory analysis and combined interpretation

Each component is analyzed separately. Processing times may differ, so the expected timing of the complete report should be confirmed when the test is scheduled. The final results should be interpreted as a group and in relation to symptoms rather than treating one isolated value as a diagnosis.

What an abnormal result may mean for the next step

• Elevated fecal calprotectin: may lead to gastroenterology assessment, repeat measurement, additional stool testing, colonoscopy, or other investigation of intestinal inflammation.
• Positive occult blood: usually requires evaluation of a possible bleeding source, often through gastroenterology assessment and endoscopy.
• Positive or clinically relevant H. pylori typing: may lead to medical review, treatment planning, later confirmation of eradication, or gastroscopy when symptoms or warning signs justify it.
• Abnormal gastrin or pepsinogen pattern: may lead to further assessment of the stomach lining and possible gastroscopy.

An abdominal ultrasound may be more appropriate when pain is located in the upper right or central abdomen or when the clinical picture suggests a gallbladder, liver, biliary, or pancreatic cause. These organs are not directly evaluated by this panel. Persistent diarrhea may also require additional stool testing for infectious, inflammatory, digestive, or other causes not included in the package.

Limitations and medical assessment

A normal panel does not rule out reflux disease, irritable bowel syndrome, celiac disease, food-related disorders, gallbladder disease, pancreatic conditions, colorectal disease, or other gastrointestinal problems. Endoscopy, ultrasound, imaging, additional laboratory tests, or specialist examination may still be appropriate when symptoms persist.

Routine laboratory testing should not delay urgent assessment for severe or rapidly worsening abdominal pain, black or visibly bloody stool, vomiting blood, repeated vomiting with inability to drink, fainting, severe weakness, marked dehydration, swallowing difficulty, or unexplained weight loss.

Preparing an inquiry

Before sending an inquiry, note when the symptoms began, their relationship with meals, any change in bowel habits, stool appearance, visible bleeding, weight change, medication, previous H. pylori treatment, and available laboratory, ultrasound, gastroscopy, or colonoscopy reports. This information can help clarify whether the Digestive Health Panel is an appropriate first step or whether a gastroenterology examination or another diagnostic service should be arranged first.

Send an inquiry with a short symptom history and any existing medical documentation to clarify the appropriate testing and appointment pathway in Zagreb.